During the past decade, Hospital Materno-Infantil Inguarán conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Materno-Infantil Inguarán" #1 collaborator was "Nationwide Children's Hospital" with 2 trials as a collaborator and "International Centre for Diarrhoeal Disease Research, Bangladesh" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Materno-Infantil Inguarán" are "Preeclampsia" (3 trials). Many other conditions were trialed in "Hospital Materno-Infantil Inguarán" in a lesser frequency.

Most popular intervention types in "Hospital Materno-Infantil Inguarán" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Congo Red Dot Test" (1 trials), "Congo Red Dot test" (1 trials) and "Congo Red test GV-005" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Materno-Infantil Inguarán" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Materno-Infantil Inguarán". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Materno-Infantil Inguarán, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Materno-Infantil Inguarán, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".